Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double-blind comparison with sulphasalazine. 1988

P B McIntyre, and C A Rodrigues, and J E Lennard-Jones, and I G Barrison, and J G Walker, and J H Baron, and P C Thornton
St Mark's Hospital, London, UK.

Balsalazide (BSZ) is a pro-drug which releases 5-aminosalicylic acid (5ASA) and 4-aminobenzoyl-beta-alanine (an inert carrier) in the colon of various species including man. BSZ was compared with sulphasalazine (SASP) (both 1 g b.d. orally) in the maintenance of remission in patients with ulcerative colitis (UC). Seventy-nine patients (53 male, 26 female), mean age 49 years (range 19-79 years), with UC were randomly allocated to either treatment (41 BSZ, 38 SASP) for 6 months. The groups were similar in respect of age, sex, duration and extent of disease. Seven patients defaulted (3 BSZ, 4 SASP) leaving 38 on BSZ and 34 on SASP. Two male patients, both receiving SASP, were withdrawn because of severe side-effects. One of these patients, with an exfoliative rash, was maintained satisfactorily on open BSZ. Remission rates at 6 months (51% BSZ, 63% SASP) were not significantly different (life-table analysis P less than 0.1). Twelve patients (15%) reported troublesome side-effects (2 BSZ 5%, 10 SASP 26%, P = 0.017 Fisher Exact Test). Mean haemoglobin concentrations, similar on entry, increased after 6 months with BSZ (0.2 g/dl) but decreased with SASP (0.5 g/dl) (P less than 0.0002). BSZ was not significantly different from SASP in maintaining remission in patients with UC but had fewer side-effects.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010659 Phenylhydrazines Diazo derivatives of aniline, used as a reagent for sugars, ketones, and aldehydes. (Dorland, 28th ed)
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000636 Aminosalicylic Acids A group of 2-hydroxybenzoic acids that can be substituted by amino groups at any of the 3-, 4-, 5-, or 6-positions. Acids, Aminosalicylic

Related Publications

P B McIntyre, and C A Rodrigues, and J E Lennard-Jones, and I G Barrison, and J G Walker, and J H Baron, and P C Thornton
January 1988, Scandinavian journal of gastroenterology. Supplement,
P B McIntyre, and C A Rodrigues, and J E Lennard-Jones, and I G Barrison, and J G Walker, and J H Baron, and P C Thornton
May 1981, British medical journal (Clinical research ed.),
P B McIntyre, and C A Rodrigues, and J E Lennard-Jones, and I G Barrison, and J G Walker, and J H Baron, and P C Thornton
May 1995, European journal of gastroenterology & hepatology,
P B McIntyre, and C A Rodrigues, and J E Lennard-Jones, and I G Barrison, and J G Walker, and J H Baron, and P C Thornton
March 1980, Gut,
P B McIntyre, and C A Rodrigues, and J E Lennard-Jones, and I G Barrison, and J G Walker, and J H Baron, and P C Thornton
May 1989, Gut,
P B McIntyre, and C A Rodrigues, and J E Lennard-Jones, and I G Barrison, and J G Walker, and J H Baron, and P C Thornton
June 2002, The American journal of gastroenterology,
P B McIntyre, and C A Rodrigues, and J E Lennard-Jones, and I G Barrison, and J G Walker, and J H Baron, and P C Thornton
April 2009, Digestive diseases and sciences,
P B McIntyre, and C A Rodrigues, and J E Lennard-Jones, and I G Barrison, and J G Walker, and J H Baron, and P C Thornton
October 1988, Gut,
P B McIntyre, and C A Rodrigues, and J E Lennard-Jones, and I G Barrison, and J G Walker, and J H Baron, and P C Thornton
April 2008, Expert review of gastroenterology & hepatology,
P B McIntyre, and C A Rodrigues, and J E Lennard-Jones, and I G Barrison, and J G Walker, and J H Baron, and P C Thornton
January 2002, Alimentary pharmacology & therapeutics,
Copied contents to your clipboard!